Competitive strategies in the pharmaceutical industry /

Saved in:
Bibliographic Details
Other Authors: Helms, Robert B. (Editor)
Format: Online
Language:English
Published: Washington, D.C. : The AEI Press, 1996.
Series:American Enterprise Institute library.
Subjects:
Online Access:HeinOnline American Enterprise Institute Library
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000cam a2200000 i 4500
001 ccn00935954
006 m fo d
007 cr bn nnnauuuu
008 200713s1996 dcua ob 001 0 eng d
040 |a NjRocCCS  |b eng  |e rda  |c NjRocCCS 
245 0 0 |a Competitive strategies in the pharmaceutical industry /  |c edited by Robert B. Helms. 
264 1 |a Washington, D.C. :  |b The AEI Press,  |c 1996. 
264 2 |a [Getzville, New York] :  |b William S. Hein & Company,  |c [2020] 
300 |a 1 online resource (xviii, 376 pages) :  |b illustrations. 
336 |a text  |2 rdacontent 
337 |a computer  |2 rdamedia 
338 |a online resource  |2 rdacarrier 
490 1 |a HeinOnline American Enterprise Institute library 
504 |a Includes bibliographical references and index. 
505 0 0 |t Generics and the producer price index for pharmaceuticals /  |r Zvi Griliches and Iain M. Cockburn --  |t An updated and extended study of the price growth of prescription pharmaceutical preparations /  |r Ernst R. Berndt and Paul E. Greenberg --  |t Measuring quality change in the market for anti-ulcer drugs /  |r Valerie Y. Suslow --  |t The uses and abuses of international price comparisons /  |r Patricia M. Danzon --  |t Industrial policy and international competitiveness in the pharmaceutical industry /  |r Lacy Glenn Thomas III --  |t R&D productivity and global market share in the pharmaceutical industry /  |r Donald L. Alexander --  |t The determinants of research productivity in ethical drug discovery /  |r Rebecca Henderson and Iain M. Cockburn --  |t Prospects for returns to pharmaceutical R&D under health care reform /  |r Henry G. Grabowski and John M. Vernon --  |t Measuring pharmaceutical industry risk and the cost of capital /  |r Stewart C. Myers and Lakshmi Shyam-Sunder --  |t Effects of research and promotion on rates of return /  |r Kenneth W. Clarkson --  |t New uses for old drugs /  |r J. Howard Beales III --  |t The leverage principle in the FDA's regulation of information /  |r John E. Calfee --  |t Costs and benefits of cost-benefit analysis in pharmaceutical promotion and utilization decisions /  |r Ronald W. Hansen. 
588 |a Description based on PDF title page, viewed July 13, 2020. 
650 0 |a Pharmaceutical industry. 
650 0 |a Drugs  |x Prices. 
650 0 |a Competition, International. 
655 0 |a Electronic books. 
700 1 |a Helms, Robert B.,  |e editor. 
710 2 |a American Enterprise Institute for Public Policy Research,  |e issuing body. 
776 0 8 |c Original  |w (DLC) 95018401  |z 0844738824  |z 0844738832 
830 0 |a American Enterprise Institute library. 
856 4 0 |3 HeinOnline American Enterprise Institute Library  |u http://ezp1.villanova.edu/login?url=https://www.heinonline.org/HOL/Page?handle=hein.amenin/aeiabav0001&id=1&size=2&collection=amenin&index=alpha/C_ameninpubs 
949 |a HD 9665.5 .C66 1996  |w LC  |c 1  |i 935954-1001  |d 7/13/2020  |l MAIN  |m HEN  |q 2  |r Y  |s Y  |t WEB  |u 7/10/2020  |x ENG 
997 |a ©2020 Cassidy Cataloguing Services, Inc. 
998 |a inter 
999 |c 245666 
852 |a Law Library  |b online